Edward Jenner Research Group LLC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials
• Graves' disease and hyperthyroidism1 trial
• Sickle cell disease1 trial
• Type 1 diabetes1 trial
• Ulcerative colitis1 trial

Phase

• Phase 12 trials
• Phase 22 trials
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Rise Therapeutics LLC2 trials
• Upstream Bio Inc.2 trials
• Pfizer1 trial
• Viridian Therapeutics, Inc.1 trial

Running trials

• Active, not recruiting

  A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

  NCT06966479· Phase 2· Upstream Bio Inc.· Source

• Active, not recruiting

  A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

  NCT06812325· Phase 3· Viridian Therapeutics, Inc.· Source

• Recruiting

  R-3750 in Patients With Mild to Moderate Ulcerative Colitis

  NCT05666960· Phase 1· Rise Therapeutics LLC· Source

  Contact: Rosario Beltran

• Recruiting

  A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  NCT05431088· Phase 2/3· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Sickle cell disease1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

  NCT06196879· Phase 2· Upstream Bio Inc.· Source

• Completed

  R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

  NCT06057454· Phase 1· Rise Therapeutics LLC· Source